Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28978805
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 JCI+Insight
2017 ; 2
(19
): ä Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Fibroblast activation protein augments progression and metastasis of pancreatic
ductal adenocarcinoma
#MMPMID28978805
Lo A
; Li CP
; Buza EL
; Blomberg R
; Govindaraju P
; Avery D
; Monslow J
; Hsiao M
; Puré E
JCI Insight
2017[Oct]; 2
(19
): ä PMID28978805
show ga
Pancreatic ductal adenocarcinomas (PDAs) are desmoplastic and can undergo
epithelial-to-mesenchymal transition to confer metastasis and chemoresistance.
Studies have demonstrated that phenotypically and functionally distinct stromal
cell populations exist in PDAs. Fibroblast activation protein-expressing
(FAP-expressing) cells act to enhance PDA progression, while ?-smooth muscle
actin myofibroblasts can restrain PDA. Thus, identification of precise molecular
targets that mediate the protumorigenic activity of FAP+ cells will guide
development of therapy for PDA. Herein, we demonstrate that FAP overexpression in
the tumor microenvironment correlates with poor overall and disease-free survival
of PDA patients. Genetic deletion of FAP delayed onset of primary tumor and
prolonged survival of mice in the KPC mouse model of PDA. While genetic deletion
of FAP did not affect primary tumor weight in advanced disease, FAP deficiency
increased tumor necrosis and impeded metastasis to multiple organs.
Lineage-tracing studies unexpectedly showed that FAP is not only expressed by
stromal cells, but can also be detected in a subset of CD90+ mesenchymal PDA
cells, representing up to 20% of total intratumoral FAP+ cells. These data
suggest that FAP may regulate PDA progression and metastasis in cell-autonomous
and/or non-cell-autonomous fashions. Together, these data support pursuing FAP as
a therapeutic target in PDA.